![]()
|
|
||||||||
J. Biol. Chem., Vol. 277, Issue 32, 29315-29320, August 9, 2002
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
§¶,
**, and
From the
Fukuda Initiative Research Unit, RIKEN (the
Institute of Physical and Chemical Research), 2-1 Hirosawa, Wako,
Saitama 351-0198, Japan, the § Laboratory for Developmental
Neurobiology, Brain Science Institute, RIKEN, 2-1 Hirosawa, Wako,
Saitama 351-0198, Japan, the
Division of Biomolecular Imaging,
Department of Basic Medical Science, Institute of Medical Science,
University of Tokyo, Minato-ku Tokyo 108-8639, Japan,
** PRESTO, JST, Kawaguchi, Saitama 332-0012, Japan, and the

Division of Molecular Neurobiology,
Department of Basic Medical Science, Institute of Medical Science,
University of Tokyo, 4-6-1 Shirokanedai, Minato-ku,
Tokyo 108-8639, Japan
Received for publication, February 19, 2002, and in revised form, May 14, 2002
| |
ABSTRACT |
|---|
|
|
|---|
Synaptotagmin VII (Syt VII), a proposed regulator
for Ca2+-dependent exocytosis, showed a
robust Ca2+-dependent oligomerization property
via its two C2 domains (Fukuda, M., and Mikoshiba, K. (2001)
J. Biol. Chem. 276, 27670-27676), but little is known
about its structure or the critical residues directly involved in the
oligomerization interface. In this study, site-directed mutagenesis and
chimeric analysis between Syt I and Syt VII showed that three Asp
residues in Ca2+-binding loop 1 or 3 (Asp-172, Asp-303, and
Asp-357) are crucial to robust Ca2+-dependent
oligomerization. Unlike Syt I, however, the polybasic sequence in the
Neuronal exocytosis is an extremely rapid process precisely
controlled by Ca2+ ions. Ca2+-binding proteins
(so-called "Ca2+ sensors") must be present in the
synaptic vesicle to achieve fusion of synaptic vesicles with the
presynaptic plasma membrane in response to the rapid increase in
Ca2+ ions (reviewed in Ref. 1). Genetic, structural, and
biochemical studies during the past decade have indicated that
synaptotagmin I (Syt I),1 an
abundant synaptic vesicle protein, is the most likely candidate for the
major Ca2+ sensor for neurotransmitter release in the
central nervous system (Ref. 2; for reviews, see Refs. 3-6). Syt I
contains one transmembrane domain and two C2 Ca2+-binding
modules (the membrane-proximal C2A domain and membrane distal C2B
domain) in the large cytoplasmic domain. The two C2 domains exhibit
completely different biochemical properties in terms of phospholipid
binding (3, 7) and play distinct roles in synaptic vesicle trafficking
(8-10). Ca2+ binding to the C2A domain stimulates
interaction with negatively charged phospholipids (2, 11-13), whereas
Ca2+ binding to the C2B domain promotes clustering of the
C2B domain in vitro (14-20). Whereas these
Ca2+-dependent actions of the C2 domains are
now believed to be an essential component of synaptic vesicle
exocytosis, how they drive membrane fusion in response to
Ca2+ remains unknown. The manner in which C2B
oligomer is assembled (i.e. structure of
Ca2+-dependent oligomer) on the synaptic
vesicle is also unknown.
Syt has been found to comprise a large family of molecules both in
vertebrates and in invertebrates (e.g.
Drosophilia, Caenorhabditis elegans, and
Arabidopsis thaliana) (Ref. 21 and references therein) and
to share the same domain structure: an N-terminal single transmembrane domain, a spacer domain of varying length, two C2 domains, and a short
carboxyl terminus (3-6). However, the Ca2+-binding ability
of the C2A domain differs among murine Syt isoforms, and some of them
fail to bind Ca2+ ions as a result of amino acid
substitutions of key Asp/Glu residues responsible for Ca2+
binding (13, 22-24).2 The
Ca2+-dependent oligomerization activity of the
C2B domain and inositol polyphosphate binding activity also differs
among the Syt isoforms (18, 19, 25, 26), and these diversities among
the C2 domains of the Syt isoforms suggest that the members of the Syt
family probably have distinct functions in membrane trafficking.
However, with the exception of Syt I, the exact roles of the Syt
isoforms (e.g. Syt III and Syt VII) in membrane trafficking
are still a matter of controversy (27-31).
Our previous study showed that Syt VII has the strongest
Ca2+-dependent self-oligomerization capacity in
the Syt family (18, 19) and that both the C2A and C2B domains of Syt
VII function as a Ca2+-dependent
oligomerization site (i.e. Syt VII has "two hands") (32). Although Syt VII has recently been proposed to regulate several
Ca2+-dependent processes (i.e.
lysosomal exocytosis, insulin secretion in pancreatic Plasmid Construction and Site-directed Mutagenesis of Mouse
Synaptotagmin VII--
Mutant Syt VII molecules carrying an Asp-to-Asn
substitution at amino acid position 172 (D172N), a D303N substitution,
a D357N substitution, or a Lys-to-Gln substitution in the C2A domain
(named the AQ mutation; K183Q, K184Q, and K186Q) were produced by PCR. The following pairs of oligonucleotides were used for amplification with pGEM-T-Syt VII as a template (35):
5'-GGTACTAGTAACCCCTTTGT-3' (D172N primer; sense),
5'-GCCATGGACATCGGGGGCACATCTTTCC-3' (D303N primer; sense),
5'-CAGGTAGATCTTGCCGATGACGTTGTT-3' (D357N primer; antisense), and 5'-AGATCTACCTGCTACCCGACCAGCAGCACCAACT-3'
(AQ primer; sense). The PCR products were purified from an agarose gel
on a Micro-Spin column (Amersham Biosciences, Inc., Buckinghamshire, UK) as described previously (35) and then directly inserted into the
pGEM-T Easy vector (Promega, Madison, WI). After verifying the
nucleotide sequences with a Hitachi SQ-5500 DNA sequencer, full-length
Syt VII mutants were constructed by replacement of appropriate inserts
at the appropriate restriction enzyme sites (underlined above) on the
pGEM-T Easy vector. A mutant Syt VII carrying a Lys-to-Gln substitution
in the C2B domain (named the BQ mutation; K320Q, K321Q, and K325Q) was
essentially produced by means of two-step PCR techniques as described
previously (25) using the following oligonucleotides:
5'-CTCTACGCGTTTGTCTTTAT-3' (BQ mutant primer 1; antisense)
and 5'-ACGCGTAGAGAAACAGCAGACTGTGACACAGAA-3'(BQ mutant
primer 2; sense). The resulting Syt VII mutant fragments were subcloned
into a modified pEF-BOS mammalian expression vector with an N-terminal
T7 or FLAG tag (7, 18, 36). All constructs were verified by DNA
sequencing as described above. pEF-T7 (or FLAG)-VII-cyto and
pEF-FLAG-Syt VI- cyto were prepared as described previously (18, 19,
37). Plasmid DNA was prepared using Wizard-mini preps (Promega)
or Qiagen (Chatsworth, CA) Maxi prep kits.
Purification of the Cytoplasmic Domain of Synaptotagmin
VII--
A glutathione S-transferase (GST) tag was added to
the N terminus of Syt VII-cyto by PCR using the pGEX-2T vector
(Amersham Biosciences) as a template:
5'-CGAGATCTATGTCCCCTATACTAGGTT-3' (GST 5'
primer; sense)
5'-GGATCCCTTGTCGTCGTCGTCCTTGTAGTCCATAGATCCACGCGGAACCAGACCACCGGTACCACCGGAACCACCATCCGATTTTGGAGGATGGTC-3' (GST-Gly linker-thrombin-FLAG primer; antisense) (FLAG tag in boldface
type, thrombin digestion site underlined, and Gly linker in italics;
see also Fig. 6A). The purified PCR products were digested
with BamHI and BglII (italicized and underlined
above) and inserted into the BamHI site of pEF-T7-Syt
VII-cyto (18) (named pEF-T7-GST-FLAG-Syt VII-cyto). T7-GST-FLAG-Syt
VII-cyto proteins expressed in COS-7 cells (10 10-cm dishes) were
solubilized with 1% Triton X-100, 50 mM HEPES-KOH, pH 7.2, and 250 mM NaCl and affinity-purified with
glutathione-Sepharose (wet volume 20 µl; Amersham Biosciences). After
extensively washing the beads with 10 mM HEPES-KOH, pH 7.2, thrombin (1 unit; Sigma) digestion was performed on the same column in
10 mM HEPES-KOH, pH 7.2, at 25 °C for 1 h. The
eluate containing FLAG-Syt VII-cyto proteins was then incubated with
benzamidine-Sepharose 6B (wet volume 20 µl; Amersham Biosciences) to
remove the thrombin. The Triton X-100 was removed with Extracti-Gel
detergent-removing gel (Pierce). Small debris was further removed by
ultracentrifugation at 100,000 × g at 4 °C for
1 h (TLA 100.4 rotor, Optima TL Ultracentrifuge; Beckman- Coulter Inc.). Protein concentrations were estimated by 10%
SDS-PAGE with bovine serum albumin as a reference.
NPY Release Assay--
NPY cDNA was a kind gift of Dr.
Wolfhard Almers (38). The addition of the C-terminal T7-GST tag
(GGSGGTGGMARMTGGQQMG + GST; Gly linker underlined) to NPY
was essentially performed by PCR as described above (39). The resulting
NPY-T7-GST fragments were subcloned into the NotI site of
the modified pShooter vector (Invitrogen) (named pShooter-NPY-T7-GST)
as described previously (40). PC12 cells (6-cm dish) were cotransfected
with 4 µg each of pShooter-NPY-T7-GST and pEF-FLAG-Syt VII-cyto by
using LipofectAMINE 2000 reagent (Invitrogen) according to the
manufacturer's notes. Three days after transfection, cells were washed
with prewarmed low KCl buffer (5.6 mM KCl, 145 mM NaCl, 2.2 mM CaCl2, 0.5 mM MgCl2, 5.6 mM glucose, and 15 mM HEPES-KOH, pH 7.4) and then stimulated with either low
KCl buffer or high KCl buffer (56 mM KCl, 95 mM NaCl, 2.2 mM CaCl2, 0.5 mM
MgCl2, 5.6 mM glucose, and 15 mM
HEPES-KOH, pH 7.4) for 10 min at 37 °C. Released NPY-T7-GST was
recovered by incubation with glutathione-Sepharose beads and analyzed
by immunoblotting with horseradish peroxidase (HRP)-conjugated anti-T7 tag antibody. The intensity of the immunoreactive bands on x-ray film
was quantified as described previously (18) and normalized by total
expressed NPY-T7-GST. Total cell lysates were obtained by incubation
with a lysis buffer (10 mM Tris-HCl, pH 8.0, 150 mM NaCl, 1 mM EDTA, and 1% Nonidet P-40, and
protease inhibitors). Under our experimental conditions, NPY-T7-GST was
targeted to dense core vesicles (data not shown), and about 5% of
total NPY-T7-GST was released only in a high KCl-dependent manner.
Electron Microscopy--
The specimens for electron microscopy
were prepared by rotary shadowing as described previously (41). In
brief, an aliquot of the purified Syt VII cytoplasmic fragment (about
50-100 µg/ml) was mixed with four volumes of 25 mM
ammonium acetate containing 50% glycerol. The mixture was immediately
sprayed onto the surface of freshly cleaved mica. Following rotary
shadowing with Pt/C (elevation angle: 6 or 8°) and backing with pure
carbon, replicas were floated off and were picked up onto copper grids.
The images were recorded with a JEM-2000ES electron microscope (JEOL)
at 80-kV acceleration voltage.
Miscellaneous Procedures--
Cotransfection of pEF-T7-Syts and
pEF-FLAG-Syts into COS-7 cells (7.5 × 105 cells, the
day before transfection, per 10-cm dish) was carried out with the
LipofectAMINE Plus reagent according to the manufacturer's instructions (Invitrogen) (42). Proteins were solubilized with a buffer
containing 1% Triton X-100, 250 mM NaCl, 50 mM
HEPES-KOH, pH 7.2, 0.1 mM phenylmethylsulfonyl fluoride, 10 µM leupeptin, and 10 µM pepstatin A at
4 °C for 1 h. T7-Syts were immunoprecipitated with anti-T7 tag
antibody-conjugated agarose (Novagen; Madison, WI) in the presence of 2 mM EGTA or 1 mM divalent cations
(MgCl2, CaCl2, SrCl2, and
BaCl2) and/or various concentrations of NaCl as described
previously (35). SDS-PAGE and immunoblotting with HRP-conjugated
anti-T7 tag (Novagen) and anti-FLAG tag antibodies (Sigma) were also
performed as described previously (18, 35, 42). The blots shown in this
paper are representative of at least three independent experiments.
Oligomerization of Synaptotagmin VII Is Selectively Stimulated by
Ca2+ and Mediated by Electrostatic Interaction--
If
oligomerization of Syt VII via the two C2 domains is crucial to the
Ca2+-regulated events previously described (27, 28, 30, 33, 34), oligomerization of Syt VII must be selectively stimulated by
Ca2+ ions and not by other divalent cations. To confirm
this, we first investigated the effect of divalent cations (1 mM) on self-oligomerization of Syt VII. The T7- and
FLAG-tagged Syt VII cytoplasmic domains (Syt VII-cyto) were coexpressed
in COS-7 cells, and the association between these two proteins was
evaluated by the immunoprecipitation method (35, 42) in the presence of
various divalent cations (1 mM). As expected,
self-oligomerization of Syt VII was selectively promoted by
Ca2+ ions, whereas Sr2+ and Ba2+
ions only marginally activated self-oligomerization. 1 mM
Mg2+ ions had no effect at all (Fig.
1A, third
panel). This divalent cation selectivity was quite similar
to that of Syt I described previously (15, 16). Since the
oligomerization of Syt VII was highly sensitive to ionic strength
(failing to occur above 750 mM of NaCl), the Syt VII
Ca2+-dependent oligomerization is most likely
to be mediated by electrostatic interaction rather than hydrophobic
interaction (Fig. 1B, third panel).
Mutational Analysis of the Ca2+-binding Loops and the
Putative C2 Effector Domains of Synaptotagmin VII--
Site-directed
mutagenesis was performed to define the oligomerization interface of
the Syt VII C2 domains (Fig. 2,
A and B). We initially focused on the Lys cluster
in the putative C2 effector domains, which is located in the
We next focused on the Asp residues in putative
Ca2+-binding loop 1 (Asp-172 in the C2A domain and Asp-303
in the C2B domain) and loop 3 (Asp-357 in the C2B domain) (43-45). The
single Ca2+-binding loop mutations (D172N, D303N, or D357N)
of the isolated C2 domain were sufficient to abolish the
Ca2+-dependent self-oligomerization activity
(Fig. 3A, third
panel). To our surprise, however, the single
Ca2+-binding loop mutations (D172N or D303N) of the full
Syt VII cytoplasmic domain resulted in normal
Ca2+-dependent self-oligomerization activity,
whereas the double Ca2+-binding loop mutations (D172N and
D303N) completely abrogated the Ca2+-dependent
self-oligomerization activity (Fig. 3B, third
panel). Similar results were obtained in regard to
Ca2+-dependent hetero-oligomerization of Syt
VII with Syt VI (compare Fig. 3, C and D,
third panels); the single D172N mutation was neutral in regard to the interaction between Syt VII-cyto and Syt
VI-cyto (Fig. 3D) but completely abrogated the interaction between Syt VII-C2A and Syt VI-cyto (Fig. 3C). In addition,
the double Ca2+-binding loop mutant (D172N and D303N) was
incapable of interacting with Syt VI-cyto even in the presence of
Ca2+ (Fig. 3D). This result markedly contrasts
with those of Syt I, because neutralization of the corresponding acidic
(Asp) residues of Syt I in the Ca2+-binding loops enhanced
the Ca2+-independent self-oligomerization activity (47).
These findings strongly indicated that the fundamental mechanism of
Ca2+-dependent self-oligomerization by Syt VII
and Syt I is different, at least in terms of oligomerization interface,
and we hypothesized that the two C2 domains of Syt VII cooperatively
mediate Ca2+-dependent self-oligomerization
(i.e. existence of a redundant Ca2+-binding
site).
Ca2+-binding Loops of Two C2 Domains Cooperatively
Mediate Ca2+-dependent Oligomerization of
Synaptotagmin VII--
If this hypothesis were true, pairing of the
C2A domain and C2B domain should be critical for
Ca2+-dependent self-oligomerization of Syt VII,
and to test this, we prepared a chimera between Syt VII and Syt I that
contains the Syt I C2A domain (named Syt VII(S1A); see Fig.
4A). The Syt VII(S1A)-cyto
protein showed weaker Ca2+-dependent
self-oligomerization activity than that of the wild-type Syt VII
protein (Fig. 4B, third panel),
probably as a result of the loss of one hand (i.e. the C2A
domain of Syt VII), because the Syt I C2A domain did not show
Ca2+-dependent self-oligomerization activity
(15, 16). It is noteworthy that the Syt VII(S1A)(D303N)-cyto protein
showed Ca2+-independent self-oligomerization activity, the
same as the Syt I Ca2+-binding mutation (47) (Fig.
4B, third panel). Thus, pairing of the
C2A and C2B domains is crucial to efficient
Ca2+-dependent self-oligomerization of Syt
VII.
Effect of Mutations in the Ca2+-binding Loops on
Ca2+-dependent NPY Release in PC12
Cells--
We then investigated the involvement of
Ca2+-dependent oligomerization of Syt VII in
Ca2+-dependent NPY-T7-GST release by expression
of wild-type or mutant (D172N/D303N) cytoplasmic fragments of Syt VII
in PC12 cells. Expression of the wild-type Syt VII-cyto in PC12 cells
resulted in about 50% inhibition of Ca2+-induced
exocytosis, whereas expression of Syt VII-cyto(D172N/D303N) completely
reversed the inhibitory effect (Fig. 5).
Ca2+-independent NPY-T7-GST release was unaltered by the
expression of recombinant proteins (data not shown). These results
suggested a critical function of Ca2+-dependent
oligomerization of the C2 domains in Ca2+-induced
exocytosis.
Structure of Ca2+-dependent Oligomerization
of Synaptotagmin VII Visualized by Rotary-shadowing Electron
Microscopy--
Finally, we attempted to visualize the structure
of the Ca2+-dependent oligomer of Syt VII by
rotary-shadowing electron microscopy. Since the bacterial recombinant
Syt VII-cyto proteins were difficult to prepare due to inclusion bodies
(data not shown), we used recombinant proteins from mammalian cultured
cells for electron microscopy. The recombinant cytoplasmic domains of
Syt VII fused to GST (Fig. 6A)
were expressed in COS-7 cells and were affinity-purified as described
under "Experimental Procedures." The purity of the recombinant Syt
VII on the SDS-polyacrylamide gel was always greater than 95% (Fig.
6B).
In the absence of Ca2+, we observed only "globular
structures," probably corresponding to the monomeric form of Syt VII
molecules (arrowheads in the middle
panel in Fig. 7). In the
presence of Ca2+, however, "linear structures" of
various length were observed in addition to the globular structures
(Fig. 7, left panel and insets),
indicating that Syt VII forms large
Ca2+-dependent oligomers (or sometimes
polymers), consistent with the results of our previous gel filtration
analysis (32). These linear structures did not have branches and
probably corresponded to the assembly of the globular structures
observed in the absence of Ca2+ (Fig. 7, left
panel). By contrast, no such linear structures were observed
in the Syt VII(D172N/D303N) mutant specimens even in the presence of
Ca2+ (globular structure, arrowheads in the
right panel of Fig. 7), consistent with the
results of immunoprecipitation described above (Fig. 3B).
These results together with the results of immunoprecipitation (Figs.
2-4 and Ref. 18) and gel filtration analyses (32) indicated that the
Ca2+-induced Syt VII oligomer is a large linear structure
and not a random aggregate.
In our previous study, we showed that a single C2 domain of Syt
VII is sufficient for Ca2+-dependent
homomultimerization and hetero-oligomerization with other Syt isoforms
(18, 19, 32), but the functional relationship between the two C2
domains and the structure of the Syt VII oligomer had never been
determined. In this paper, we have presented several lines of evidence
indicating that the two C2 domains of Syt VII are not functionally
independent and that the Ca2+-binding loops of the two C2
domains cooperatively mediate Ca2+-dependent
oligomerization. First, mutation of the single Asp residue (D172N in
the C2A domain or D303N in the C2B domain) in Ca2+-binding
loop 1 abrogated the Ca2+-dependent
self-oligomerization of the "isolated C2 domain" but was neutral in
regard to the Ca2+-dependent
self-oligomerization of the "tandem C2 domains" (Figs. 2 and 3).
The tandem C2 domains with the double mutation (D172N/D303N), however,
did not show Ca2+-dependent
self-oligomerization, suggesting the presence of redundant Ca2+-binding site(s). Second, chimeric analysis between Syt
I and Syt VII showed that pairing of the C2A and C2B domains is an
important factor for efficient Ca2+-dependent
oligomerization of Syt VII (Fig. 4). Based on these results, together
with the recent crystallographic data showing that the
Ca2+-binding regions of the two C2 domains of Syt III face
each other (45), we propose that the Ca2+-binding loops of
the two C2 domains directly contribute to formation of the
oligomerization interface; Ca2+ binding to the Asp residues
in the loops of the C2 structures changes the electrostatic charges
around the loop domains, which may directly form the oligomerization
interface between two C2 domains. This model is completely different
from the model of Syt I (or II), which also showed
Ca2+-dependent oligomerization mediated by the
C2B effector domain but not the Ca2+-binding loops
themselves (16, 20, 47). The structure of the
Ca2+-dependent oligomer of Syt I is now under
investigation in our laboratory, and it will be interesting to
determine whether the Ca2+-dependent Syt I
oligomer exhibits the same linear structure.
We also demonstrated the physiological importance of the
Ca2+-dependent oligomerization of Syt VII by
using the dominant negative approach (28, 30, 47). When the wild-type
tandem C2 fragment was expressed in PC12 cells,
Ca2+-dependent NPY release was significantly
inhibited, most likely by competing endogenous Syt proteins. By
contrast, the mutants lacking Ca2+-dependent
oligomerization activity had no effect on NPY release (Fig. 5).
Although the exact role of the Ca2+-dependent
oligomer of Syt VII in vesicular exocytosis is unknown, based on the
structure of the Ca2+-dependent oligomer of Syt
VII (i.e. the linear structure) visualized by
rotary-shadowing electron microscopy (Fig. 7), it may be involved in
dilation or opening of fusion pores by aligning to form a straight line
at the fusion site between the vesicles and plasma membrane (48).
Consistent with this hypothesis, Syt I and IV have recently been shown
to modulate fusion pore kinetics in regulated exocytosis of PC12 cells
(49). Further work is necessary to examine the effect of wild-type or
mutant (D172N/D303N) expression on fusion pore kinetics to clarify the
relationship between Syt VII oligomerization and fusion pore formation.
In summary, site-directed mutagenesis and chimeric analysis in
this study demonstrated that the Ca2+-binding loops of the
two C2 domains cooperatively mediate both Ca2+-dependent oligomerization of Syt VII and
Ca2+-dependent NPY release. We have also shown
that the Ca2+-dependent Syt VII oligomer is a
linear structure, not an irregular random aggregate.
4 strands of the C2 structures (so-called "C2 effector
domain") is not involved in the
Ca2+-dependent oligomerization of Syt VII. The
results also showed that the Ca2+-binding loops of the two
C2 domains cooperatively mediate Syt VII oligomerization
(i.e. the presence of redundant Ca2+-binding
site(s)) as well as the importance of
Ca2+-dependent oligomerization of Syt VII in
Ca2+-regulated secretion. Expression of wild-type tandem C2
domains of Syt VII in PC12 cells inhibited
Ca2+-dependent neuropeptide Y release, whereas
mutant fragments lacking Ca2+-dependent
oligomerization activity had no effect. Finally, rotary-shadowing electron microscopy showed that the
Ca2+-dependent oligomer of Syt VII is "a
large linear structure," not an irregular aggregate. By contrast, in
the absence of Ca2+ Syt VII molecules were observed to form
a globular structure. Based on these results, we suggest that the
linear Ca2+-dependent oligomer may be aligned
at the fusion site between vesicles and plasma membrane and modulate
Ca2+-regulated exocytosis by opening or dilating fusion pores.
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
-cells, and
norepinephrine release in PC12 cells) (27, 28, 30, 33, 34), little is
known about the functional involvement of the
Ca2+-dependent self-oligomerization of Syt VII
in these Ca2+-regulated events, the structure of the
Ca2+-dependent oligomer, or the critical
residues directly involved in the oligomerization interface. In this
study, we attempt to identify the residues (or an oligomerization
interface) critical to the Ca2+-dependent
oligomerization of Syt VII and the functional relationship between the
two C2 domains. We show by site-directed mutagenesis that, unlike Syt
I, Ca2+-dependent homo- and
hetero-oligomerization of Syt VII are cooperatively mediated by the
Ca2+-binding loops of the two C2 domains, not by the
putative C2 effector domains. Moreover, whereas expression of the
wild-type cytoplasmic tandem C2 domains in PC12 cells inhibited
Ca2+-dependent neuropeptide Y (NPY) release,
mutant proteins incapable of Ca2+-dependent
oligomerization had no effect on NPY release. Furthermore, we show by
rotary-shadowing electron microscopy that the
Ca2+-dependent Syt VII oligomer has a linear
structure and is not a random aggregate. Based on these findings, we
discuss how the Ca2+-dependent Syt oligomer
regulates vesicular exocytosis.
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

View larger version (29K):
[in a new window]
Fig. 1.
Ca2+ selectively promotes
synaptotagmin VII clustering. A, effect of divalent
cations on Ca2+-dependent oligomerization of
Syt VII. B, Ca2+-dependent
oligomerization of Syt VII is sensitive to ionic strength. pEF-T7-Syt
VII-cyto and pEF-FLAG-Syt VII-cyto were cotransfected into COS-7 cells.
The proteins expressed were solubilized with 1% Triton X-100 and
immunoprecipitated with anti-T7 tag antibody-conjugated agarose
(IP) in the presence of the divalent cations indicated (1 mM in A) or in the presence of 1 mM
Ca2+ and the concentrations of NaCl indicated (in
B) (32, 35). Co-immunoprecipitated FLAG-Syts were first
detected with HRP-conjugated anti-FLAG tag antibody (1:10,000 dilution;
third panels). The same blots were stripped and
reprobed with HRP-conjugated anti-T7 tag antibody to ensure loading of
the same amounts of T7-Syt proteins (1:10,000 dilution;
bottom panels). The top two
panels indicate the total expressed T7-Syt VII-cyto and
FLAG-Syt VII-cyto proteins ( 
3) are
shown on the left.
4 strand (Lys-183, Lys-184, and Lys-186 in the C2A domain and
Lys-320, Lys-321, and Lys-325 in the C2B domain, corresponding to the
"C2B effector domain" of Syt I) of the C2
-sandwich structure
(16, 25, 43-46), because neutralization of these basic residues
(Lys-to-Gln or Lys-to-Ala substitution) completely abrogated the
Ca2+-dependent self-oligomerization of Syts I
and II (16, 20). However, neutralization of all three basic residues in
the C2A domain (named the AKQ mutation) and C2B domain (BKQ mutation) had no effect on the Ca2+-dependent
self-oligomerization activity (Fig. 2C, third
panel), although the AKQ mutation slightly increased the
Ca2+-independent self-oligomerization activity.

View larger version (39K):
[in a new window]
Fig. 2.
Effect of mutations in the putative C2
effector domains on Ca2+-dependent
oligomerization of synaptotagmin VII. A, schematic
representation of substitution mutants of Syt VII. The transmembrane
domain (TM) and two C2 domains are represented by the
open box and shaded boxes,
respectively. Position numbers of amino acids are indicated on
both sides. Amino acid substitutions are
indicated by arrowheads. B, schematic
representation of the structure of the C2 domains of Syt VII (modified
from Ref. 44). The arrows represent eight
strands of the
C2 domain (
1-
8). Three loops are formed at the top of the
-sandwich structure, and two of them are involved in
Ca2+ binding in the C2A domain of Syt I (43-45). The
overall structure of the two C2 domains is quite similar, but an
additional
-helix is present between the
7 and
8 strands in
the C2B domain (45). Five Asp residues in the C2A domain (or in the C2B
domain; parentheses) are thought to be crucial to
Ca2+ binding, by analogy with the C2A domain of Syt I (44).
KKK indicates the putative C2 effector domain in the
4
strands (16, 25). C, Ca2+-dependent
self-oligomerization of Syt VII with the mutations in the C2 effector
domains (AKQ and BKQ). pEF-T7-Syt VII-cyto and pEF-FLAG-Syt VII-cyto
were cotransfected into COS-7 cells. The proteins expressed were
solubilized with 1% Triton X-100 and immunoprecipitated with anti-T7
tag antibody-conjugated agarose (IP) in the presence or
absence of 1 mM Ca2+ as described previously
(32, 35). Co-immunoprecipitated FLAG-Syts were first detected with
HRP-conjugated anti-FLAG tag antibody (1:10,000 dilution;
third panel in C). The same blot was
stripped and reprobed with HRP-conjugated anti-T7 tag antibody to
ensure loading of the same amounts of T7-Syt proteins (1:10,000
dilution; bottom panel in C). The
top two panels indicate the total
expressed T7-Syt VII-cyto and FLAG-Syt VII-cyto proteins (

View larger version (46K):
[in a new window]
Fig. 3.
Effect of mutations in the
Ca2+-binding loops on self-oligomerization of the single C2
domain and tandem C2 domains of synaptotagmin VII. A,
Ca2+-dependent self-oligomerization of the
single C2 domain of Syt VII with Ca2+-binding loop
mutations (D172N, D303N, or D357N). B,
Ca2+-dependent self-oligomerization of the
tandem C2 domains of Syt VII with the mutations in the
Ca2+-binding loops (D172N and/or D303N). C,
Ca2+-dependent hetero-oligomerization of T7-Syt
VII-C2A mutant with FLAG-Syt VI-cyto. D,
Ca2+-dependent hetero-oligomerization of T7-Syt
VII-cyto mutants with FLAG-Syt VI-cyto. pEF-T7-Syts and pEF-FLAG-Syts
were cotransfected into COS-7 cells. The proteins expressed were
solubilized with 1% Triton X-100 and immunoprecipitated with anti-T7
tag antibody-conjugated agarose (IP) in the presence or
absence of 1 mM Ca2+ as described previously
(32, 35). Co-immunoprecipitated FLAG-Syts were first detected with
HRP-conjugated anti-FLAG tag antibody (1:10,000 dilution;
third panels in A-D). The same blots
were stripped and reprobed with HRP-conjugated anti-T7 tag antibody to
ensure loading of the same amounts of T7-Syt proteins (1:10,000
dilution; bottom panels in A-D). The
top two panels indicate the total
expressed T7-Syt and FLAG-Syt proteins ( 

View larger version (20K):
[in a new window]
Fig. 4.
Ca2+-dependent
oligomerization property of the C2A chimera between Syt VII and Syt
I. A, schematic representation of the C2A chimera
between Syt I and Syt VII (named Syt VII(S1A)). The transmembrane
domain (TM), Syt I C2A domain, and Syt VII C2B domain are
represented by the open box, hatched box, and shaded
box, respectively. B,
Ca2+-dependent self-oligomerization of Syt
VII(S1A) mutants. pEF-T7-Syt VII(S1A)-cyto and pEF-FLAG-Syt
VII(S1A)-cyto were cotransfected into COS-7 cells. The proteins
expressed were solubilized with 1% Triton X-100 and immunoprecipitated
with anti-T7 tag antibody-conjugated agarose (IP) in the
presence or absence of 1 mM Ca2+ as described
previously (32, 35). Co-immunoprecipitated FLAG-Syts were first
detected with HRP-conjugated anti-FLAG tag antibody (1:10,000 dilution;
third panel in B). The same blot was
stripped and reprobed with HRP-conjugated anti-T7 tag antibody to
ensure loading of the same amounts of T7-Syt proteins (1:10,000
dilution; bottom panel in B). The
top two panels indicate the total
expressed T7-Syt VII(S1A)-cyto and FLAG-Syt VII(S1A)-cyto proteins
( 

View larger version (37K):
[in a new window]
Fig. 5.
Ca2+-triggered NPY release
requires an intact Ca2+ binding site in the tandem C2
domains of synaptotagmin VII. PC12 cells expressing Syt VII tandem
C2 domains were stimulated by high KCl buffer, and the NPY-T7-GST
released was measured by immunoprecipitation as described under
"Experimental Procedures." The results are expressed as percentage
of NPY-T7-GST release compared with control samples without expression
of recombinant proteins. Note that expression of the wild-type fragment
dramatically reduced the Ca2+-dependent
NPY-T7-GST release (*, p < 0.01, Student's unpaired
t test) (open bar), whereas expression
of the mutant protein (D172N/D303N) had no significant effect
(closed bar). Bars indicate the
mean ± S.E. of three determinations. The inset shows
the similar expression levels of the wild-type and DN (D172N/D303N)
mutant proteins visualized by HRP-conjugated anti-FLAG tag antibody.
The arrowhead indicates the nonspecific interaction of
anti-FLAG tag antibody. The results shown are representative of three
independent experiments.

View larger version (17K):
[in a new window]
Fig. 6.
Purification of cytoplasmic fragments of
synaptotagmin VII. A, schematic representation of the
GST-tagged Syt VII cytoplasmic domain (amino acids 43-403). T7-tag,
GST, and two C2 domains are represented by the black
box, hatched box, and
shaded boxes, respectively. B,
pEF-T7-GST-FLAG-Syt VII-cyto was transfected into COS-7 cells. The
proteins expressed were solubilized with 1% Triton X-100 and
affinity-purified by glutathione-Sepharose beads. The GST tag was
removed by thrombin digestion as described under "Experimental
Procedures." Purified FLAG-Syt VII-cyto proteins were analyzed by
10% SDS-PAGE and staining with Coomassie Brilliant Blue R-250. The
authenticity of the bands (FLAG-Syt VII-cyto) was confirmed by
immunoblotting with HRP-conjugated anti-FLAG tag antibody (data not
shown). The positions of the molecular weight markers (MW)
(× 10
3) are shown on the left. WT,
wild type.

View larger version (147K):
[in a new window]
Fig. 7.
Rotary-shadowing electron microscopy of
Ca2+-dependent synaptotagmin VII polymer.
Left panel and insets, various lengths of Syt VII
polymer (linear structures) in the presence of 1 mM
Ca2+. Middle panel, globular structures
(arrowheads) of Syt VII in the absence of Ca2+.
Right panel, globular structures of Syt
VII(D172N/D303N) mutants in the presence of Ca2+.
Scale bar, 100 nm.
![]()
DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
| |
ACKNOWLEDGEMENTS |
|---|
We thank Dr. Wolfhard Almers (Vollum Institute, Portland, OR) for kindly donating a cDNA of NPY, Dr. Benoit R. Gauthier and Dr. Claes B. Wollheim (Geneva University Medical Center, Geneva, Switzerland) for helpful discussions, and Eiko Kanno and Yukie Ogata for technical assistance.
| |
FOOTNOTES |
|---|
* This work was supported in part by a grant from the Human Frontier Science Program (to K. M.) and Ministry of Education, Science, and Culture of Japan Grant 13780624 (to M. F.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
¶ To whom correspondence should be addressed: Fukuda Initiative Research Unit, RIKEN, 2-1 Hirosawa, Wako, Saitama 351-0198, Japan. Tel.: 81-48-462-4994; Fax: 81-48-462-4995; E-mail: mnfukuda@brain.riken.go.jp.
Published, JBC Papers in Press, May 28, 2002, DOI 10.1074/jbc.M201697200
2 Fukuda, M. (2002) Biochem. J. 10.1042/BJ20020484.
| |
ABBREVIATIONS |
|---|
The abbreviations used are: Syt, synaptotagmin; GST, glutathione S-transferase; HRP, horseradish peroxidase; NPY, neuropeptide Y.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Bennett, M. R. (1999) Prog. Neurobiol. 59, 243-277[CrossRef][Medline] [Order article via Infotrieve] |
| 2. | Fernandez-Chacon, R., Konigstorfer, A., Gerber, S. H., Garcia, J., Matos, M. F., Stevens, C. F., Brose, N., Rizo, J., Rosenmund, C., and Südhof, T. C. (2001) Nature 410, 41-49[CrossRef][Medline] [Order article via Infotrieve] |
| 3. | Marquèze, B., Berton, F., and Seagar, M. (2000) Biochimie (Paris) 82, 409-420[Medline] [Order article via Infotrieve] |
| 4. | Südhof, T. C., and Rizo, J. (1996) Neuron 17, 379-388[CrossRef][Medline] [Order article via Infotrieve] |
| 5. | Fukuda, M., and Mikoshiba, K. (1997) Bioessays 19, 593-603[CrossRef][Medline] [Order article via Infotrieve] |
| 6. | Schiavo, G., Osborne, S. L., and Sgouros, J. G. (1998) Biochem. Biophys. Res. Commun. 248, 1-8[CrossRef][Medline] [Order article via Infotrieve] |
| 7. |
Fukuda, M.,
Aruga, J.,
Niinobe, M.,
Aimoto, S.,
and Mikoshiba, K.
(1994)
J. Biol. Chem.
269,
29206-29211 |
| 8. |
Mikoshiba, K.,
Fukuda, M.,
Moreira, J. E.,
Lewis, F. M. T.,
Sugimori, M.,
Niinobe, M.,
and Llinás, R.
(1995)
Proc. Natl. Acad. Sci. U. S. A.
92,
10703-10707 |
| 9. |
Fukuda, M.,
Moreira, J. E.,
Lewis, F. M. T.,
Sugimori, M.,
Niinobe, M.,
Mikoshiba, K.,
and Llinás, R.
(1995)
Proc. Natl. Acad. Sci. U. S. A.
92,
10708-10712 |
| 10. |
Fukuda, M.,
Moreira, J. E.,
Liu, V.,
Sugimori, M.,
Mikoshiba, K.,
and Llinás, R. R.
(2000)
Proc. Natl. Acad. Sci. U. S. A.
97,
14715-14719 |
| 11. |
Davletov, B. A.,
and Südhof, T. C.
(1993)
J. Biol. Chem.
268,
26386-26390 |
| 12. |
Chapman, E. R.,
and Jahn, R.
(1994)
J. Biol. Chem.
269,
5735-5741 |
| 13. |
Fukuda, M.,
Kojima, T.,
and Mikoshiba, K.
(1996)
J. Biol. Chem.
271,
8430-8434 |
| 14. | Damer, C. K., and Creutz, C. E. (1996) J. Neurochem. 67, 1661-1668[Medline] [Order article via Infotrieve] |
| 15. |
Sugita, S.,
Hata, Y.,
and Südhof, T. C.
(1996)
J. Biol. Chem.
271,
1262-1265 |
| 16. |
Chapman, E. R.,
Desai, R. C.,
Davis, A. F.,
and Tornehl, C. K.
(1998)
J. Biol. Chem.
273,
32966-32972 |
| 17. |
Osborne, S. L.,
Herreros, J.,
Bastiaens, P. I. H.,
and Schiavo, G.
(1999)
J. Biol. Chem.
274,
59-66 |
| 18. |
Fukuda, M.,
and Mikoshiba, K.
(2000)
J. Biol. Chem.
275,
28180-28185 |
| 19. |
Fukuda, M.,
and Mikoshiba, K.
(2000)
J. Biochem. (Tokyo)
128,
637-645 |
| 20. | Fukuda, M., Kabayama, H., and Mikoshiba, K. (2000) FEBS Lett. 482, 269-272[CrossRef][Medline] [Order article via Infotrieve] |
| 21. | Craxton, M. (2001) Genomics 77, 43-49[CrossRef][Medline] [Order article via Infotrieve] |
| 22. | Li, C., Ullrich, B., Zhang, J. Z., Anderson, R. G. W., Brose, N., and Südhof, T. C. (1995) Nature 375, 594-599[CrossRef][Medline] [Order article via Infotrieve] |
| 23. |
von Poser, C.,
Ichtchenko, K.,
Shao, X.,
Rizo, J.,
and Südhof, T. C.
(1997)
J. Biol. Chem.
272,
14314-14319 |
| 24. | Fukuda, M., and Mikoshiba, K. (2001) Biochem. J. 354, 249-257[CrossRef][Medline] [Order article via Infotrieve] |
| 25. |
Fukuda, M.,
Kojima, T.,
Aruga, J.,
Niinobe, M.,
and Mikoshiba, K.
(1995)
J. Biol. Chem.
270,
26523-26527 |
| 26. |
Ibata, K.,
Fukuda, M.,
and Mikoshiba, K.
(1998)
J. Biol. Chem.
273,
12267-12273 |
| 27. |
Martinez, I.,
Chakrabarti, S.,
Hellevik, T.,
Morehead, J.,
Fowler, K.,
and Andrews, N. W.
(2000)
J. Cell Biol.
148,
1141-1149 |
| 28. | Sugita, S., Han, W., Butz, S., Liu, X., Fernandez-Chacon, R., Lao, Y., and Südhof, T. C. (2001) Neuron 30, 459-473[CrossRef][Medline] [Order article via Infotrieve] |
| 29. | Mizuta, M., Kurose, T., Miki, T., Shoji-Kasai, Y., Takahashi, M., Seino, S., and Matsukura, S. (1997) Diabetes 46, 2002-2006[Abstract] |
| 30. | Gut, A., Kiraly, C. E., Fukuda, M., Mikoshiba, K., Wollheim, C. B., and Lang, J. (2001) J. Cell Sci. 114, 1709-1716[Abstract] |
| 31. |
Saegusa, C.,
Fukuda, M.,
and Mikoshiba, K.
(2002)
J. Biol. Chem.
277,
24499-24505 |
| 32. |
Fukuda, M.,
and Mikoshiba, K.
(2001)
J. Biol. Chem.
276,
27670-27676 |
| 33. |
Gao, Z.,
Reavey-Cantwell, J.,
Young, R. A.,
Jegier, P.,
and Wolf, B. A.
(2000)
J. Biol. Chem.
275,
36079-36085 |
| 34. | Reddy, A., Caler, E. V., and Andrews, N. W. (2001) Cell 106, 157-169[CrossRef][Medline] [Order article via Infotrieve] |
| 35. |
Fukuda, M.,
Kanno, E.,
and Mikoshiba, K.
(1999)
J. Biol. Chem.
274,
31421-31427 |
| 36. | Mizushima, S., and Nagata, S. (1990) Nucleic Acids Res. 18, 5332 |
| 37. |
Fukuda, M.,
and Mikoshiba, K.
(1999)
J. Biol. Chem.
274,
31428-31434 |
| 38. | Lang, T., Wacker, I., Steyer, J., Kaether, C., Wunderlich, I., Soldati, T., Gerdes, H. H., and Almers, W. (1997) Neuron 18, 857-863[CrossRef][Medline] [Order article via Infotrieve] |
| 39. |
Fukuda, M.,
Kuroda, T. S.,
and Mikoshiba, K.
(2002)
J. Biol. Chem.
277,
12432-12436 |
| 40. | Fukuda, M., Ogata, Y., Saegusa, C., Kanno, E., and Mikoshiba, K. (2002) Biochem. J. 365, 173-180[CrossRef][Medline] [Order article via Infotrieve] |
| 41. |
Katayama, E.,
and Ikebe, M.
(1995)
Biophys. J.
68,
2419-2428 |
| 42. |
Fukuda, M.,
Kanno, E.,
Ogata, Y.,
and Mikoshiba, K.
(2001)
J. Biol. Chem.
276,
40319-40325 |
| 43. | Nalefski, E. A., and Falke, J. J. (1996) Protein Sci. 5, 2375-2390[Abstract] |
| 44. |
Rizo, J.,
and Südhof, T. C.
(1998)
J. Biol. Chem.
273,
15879-15882 |
| 45. |
Sutton, R. B.,
Ernst, J. A.,
and Brunger, A. T.
(1999)
J. Cell Biol.
147,
589-598 |
| 46. | Mizutani, A., Fukuda, M., Niinobe, M., and Mikoshiba, K. (1997) Biochem. Biophys. Res. Commun. 240, 128-131[CrossRef][Medline] [Order article via Infotrieve] |
| 47. |
Desai, R. C.,
Vyas, B.,
Earles, C. A.,
Littleton, J. T.,
Kowalchyck, J. A.,
Martin, T. F. J.,
and Chapman, E. R.
(2000)
J. Cell Biol.
150,
1125-1136 |
| 48. |
Littleton, J. T.,
Bai, J.,
Vyas, B.,
Desai, R.,
Baltus, A. E.,
Garment, M. B.,
Carlson, S. D.,
Ganetzky, B.,
and Chapman, E. R.
(2001)
J. Neurosci.
21,
1421-1433 |
| 49. |
Wang, C. T.,
Grishanin, R.,
Earles, C. A.,
Chang, P. Y.,
Martin, T. F. J.,
Chapman, E. R.,
and Jackson, M. B.
(2001)
Science
294,
1111-1115 |
This article has been cited by other articles:
![]() |
G. Patino-Lopez, X. Dong, K. Ben-Aissa, K. M. Bernot, T. Itoh, M. Fukuda, M. J. Kruhlak, L. E. Samelson, and S. Shaw Rab35 and Its GAP EPI64C in T Cells Regulate Receptor Recycling and Immunological Synapse Formation J. Biol. Chem., June 27, 2008; 283(26): 18323 - 18330. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. R. Gauthier, D. L. Duhamel, M. Iezzi, S. Theander, F. Saltel, M. Fukuda, B. Wehrle-Haller, and C. B. Wollheim Synaptotagmin VII splice variants {alpha}, , and {delta} are expressed in pancreatic -cells and regulate insulin exocytosis FASEB J, January 1, 2008; 22(1): 194 - 206. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Tsuboi and M. Fukuda Synaptotagmin VII modulates the kinetics of dense-core vesicle exocytosis in PC12 cells Genes Cells, April 1, 2007; 12(4): 511 - 519. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Itoh and M. Fukuda Identification of EPI64 as a GTPase-activating Protein Specific for Rab27A J. Biol. Chem., October 20, 2006; 281(42): 31823 - 31831. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Itoh, M. Satoh, E. Kanno, and M. Fukuda Screening for target Rabs of TBC (Tre-2/Bub2/Cdc16) domain-containing proteins based on their Rab-binding activity. Genes Cells, September 1, 2006; 11(9): 1023 - 1037. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Bhalla, W. C. Tucker, and E. R. Chapman Synaptotagmin Isoforms Couple Distinct Ranges of Ca2+, Ba2+, and Sr2+ Concentration to SNARE-mediated Membrane Fusion Mol. Biol. Cell, October 1, 2005; 16(10): 4755 - 4764. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Hui, J. Bai, P. Wang, M. Sugimori, R. R. Llinas, and E. R. Chapman Three distinct kinetic groupings of the synaptotagmin family: Candidate sensors for rapid and delayed exocytosis PNAS, April 5, 2005; 102(14): 5210 - 5214. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Grass, S. Thiel, S. Honing, and V. Haucke Recognition of a Basic AP-2 Binding Motif within the C2B Domain of Synaptotagmin Is Dependent on Multimerization J. Biol. Chem., December 24, 2004; 279(52): 54872 - 54880. [Abstract] [Full Text] [PDF] |
||||
![]() |
|